Testosterone acetate

Testosterone acetate
Clinical data
Trade names	Aceto-Sterandryl, Aceto-Testoviron, Amolisin, Androtest A, Deposteron, Farmatest, Perandrone A
Other names	Testosterone ethanoate; Testosterone 17β-acetate; Androst-4-en-17β-ol-3-one 17β-acetate
Routes of; administration	Intramuscular injection
Identifiers
	IUPAC name [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate;
CAS Number	1045-69-8;
PubChem CID	92145;
ChemSpider	83191;
UNII	5652105Y6S;
KEGG	C03027;
ChEBI	CHEBI:16524;
ChEMBL	ChEMBL488762;
CompTox Dashboard (EPA)	DTXSID80909007 ;
ECHA InfoCard	100.012.615
Chemical and physical data
Formula	C21H30O3
Molar mass	330.468 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C;
	InChI InChI=1S/C21H30O3/c1-13(22)24-19-7-6-17-16-5-4-14-12-15(23)8-10-20(14,2)18(16)9-11-21(17,19)3/h12,16-19H,4-11H2,1-3H3/t16-,17-,18-,19-,20-,21-/m0/s1; Key:DJPZSBANTAQNFN-PXQJOHHUSA-N;

Testosterone acetate (brand names Aceto-Sterandryl, Aceto-Testoviron, Amolisin, Androtest A, Deposteron, Farmatest, Perandrone A), or testosterone ethanoate, also known as androst-4-en-17β-ol-3-one 17β-acetate, is an androgen and anabolic steroid and a testosterone ester.^[1]^[2]^[3] The drug was first described in 1936 and was one of the first androgen esters and esters of testosterone to be synthesized.^[4]^[5]

References

^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 641–642. ISBN 978-1-4757-2085-3.
^ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. ISBN 978-3-88763-075-1.
^ Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. ISBN 978-94-011-4439-1.
^ Miescher K, Wettstein A, Tschopp E (November 1936). "The activation of the male sex hormones. II". The Biochemical Journal. 30 (11): 1977–1990. doi:10.1042/bj0301977. PMC 1263292. PMID 16746250.
^ Parkes AS (1936). "Increasing the Effectiveness of Testosterone". The Lancet. 228 (5899): 674–676. doi:10.1016/S0140-6736(00)80929-0. ISSN 0140-6736.

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

This article about a steroid is a stub. You can help Wikipedia by expanding it.

[Elks2014-1] Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 641–642. ISBN 978-1-4757-2085-3.

[IndexNominum2000-2] Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. ISBN 978-3-88763-075-1.

[MortonHall2012-3] Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. ISBN 978-94-011-4439-1.

[pmid16746250-4] Miescher K, Wettstein A, Tschopp E (November 1936). "The activation of the male sex hormones. II". The Biochemical Journal. 30 (11): 1977–1990. doi:10.1042/bj0301977. PMC 1263292. PMID 16746250.

[Parkes1936-5] Parkes AS (1936). "Increasing the Effectiveness of Testosterone". The Lancet. 228 (5899): 674–676. doi:10.1016/S0140-6736(00)80929-0. ISSN 0140-6736.

[1]

[2]

[3]

[4]

[5]

See also

References